KIF3A and lung cancer: Furthermore, KIF3A could bind to β‐arrestin to block the Wnt signal pathway, therefore affecting the proliferation of lung cancer cells, which is consistent with the upregulation of cyclin D1 and β‐catenin 29, 30.